ES2450423T3 - Composición farmacéutica que comprende propofol - Google Patents
Composición farmacéutica que comprende propofol Download PDFInfo
- Publication number
- ES2450423T3 ES2450423T3 ES10778677.4T ES10778677T ES2450423T3 ES 2450423 T3 ES2450423 T3 ES 2450423T3 ES 10778677 T ES10778677 T ES 10778677T ES 2450423 T3 ES2450423 T3 ES 2450423T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- propofol
- dosage form
- oral
- fluorinated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C19/00—Acyclic saturated compounds containing halogen atoms
- C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014548 | 2009-11-23 | ||
| EP09014548A EP2332525A1 (en) | 2009-11-23 | 2009-11-23 | Pharmaceutical composition comprising propofol |
| PCT/EP2010/067938 WO2011061332A1 (en) | 2009-11-23 | 2010-11-22 | Pharmaceutical composition comprising propofol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2450423T3 true ES2450423T3 (es) | 2014-03-24 |
Family
ID=41694756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10778677.4T Active ES2450423T3 (es) | 2009-11-23 | 2010-11-22 | Composición farmacéutica que comprende propofol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8796340B2 (https=) |
| EP (2) | EP2332525A1 (https=) |
| JP (1) | JP5707009B2 (https=) |
| KR (1) | KR20120104262A (https=) |
| CN (1) | CN102753159B (https=) |
| AU (1) | AU2010320823B2 (https=) |
| BR (1) | BR112012012108A2 (https=) |
| CA (1) | CA2776855C (https=) |
| ES (1) | ES2450423T3 (https=) |
| IN (1) | IN2012DN03130A (https=) |
| MX (1) | MX2012005881A (https=) |
| WO (1) | WO2011061332A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2547323T3 (pl) | 2010-03-17 | 2016-07-29 | Novaliq Gmbh | Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| DK2714010T3 (en) | 2011-05-25 | 2017-06-12 | Novaliq Gmbh | TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES |
| JP6023181B2 (ja) | 2011-05-25 | 2016-11-09 | ノバリック ゲーエムベーハー | 爪に投与するための医薬組成物 |
| GB201116271D0 (en) | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
| KR101989648B1 (ko) | 2012-01-23 | 2019-06-14 | 노바리크 게엠베하 | 부분불소화 알칸에 기초한 안정화된 단백질 조성물 |
| AU2013314303B2 (en) | 2012-09-12 | 2018-01-18 | Novaliq Gmbh | Semifluorinated alkane compositions |
| CN113679699B (zh) | 2012-09-12 | 2022-10-28 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| DK2708228T3 (en) * | 2012-09-12 | 2018-08-20 | Novaliq Gmbh | COMPOSITION FOR EYE RINSE |
| PT3024484T (pt) | 2013-07-23 | 2018-10-24 | Novaliq Gmbh | Composições de anticorpo estabilizadas |
| EP2944324A1 (de) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen |
| US20180022698A1 (en) | 2014-10-16 | 2018-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Novel methods, compounds, and compositions for anesthesia |
| US11154513B2 (en) | 2015-09-30 | 2021-10-26 | Novaliq Gmbh | Semifluorinated compounds |
| CN110403923B (zh) | 2015-09-30 | 2021-09-21 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| PT3442480T (pt) | 2016-06-23 | 2019-12-23 | Novaliq Gmbh | Método de administração tópica |
| CA3036297C (en) | 2016-09-22 | 2023-09-05 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| WO2018055101A1 (en) | 2016-09-23 | 2018-03-29 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| EP4374851B1 (en) | 2016-12-23 | 2026-04-15 | Novaliq GmbH | Ophthalmic composition for treatment of dry eye disease |
| CA3058097C (en) | 2017-04-21 | 2024-01-02 | Novaliq Gmbh | Iodine compositions |
| US11278503B2 (en) | 2017-05-12 | 2022-03-22 | Novaliq Gmbh | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions |
| MX2020003534A (es) | 2017-09-27 | 2020-07-29 | Novaliq Gmbh | Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares. |
| WO2019068763A1 (en) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | OPHTHALMIC COMPOSITIONS COMPRISING F6H8 |
| KR20200128407A (ko) | 2018-03-02 | 2020-11-12 | 노바리크 게엠베하 | 네비볼롤을 포함하는 약제학적 조성물 |
| SG11202007860XA (en) | 2018-03-28 | 2020-09-29 | Novaliq Gmbh | Pharmaceutical composition comprising timolol |
| CN112153970A (zh) | 2018-04-27 | 2020-12-29 | 诺瓦利克有限责任公司 | 用于治疗青光眼的包含他氟前列素的眼用组合物 |
| EP3856124A1 (en) | 2018-09-27 | 2021-08-04 | Novaliq GmbH | Lipid barrier repair |
| SG11202102820VA (en) | 2018-10-12 | 2021-04-29 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| EP3923907B1 (en) | 2019-02-13 | 2024-09-25 | Novaliq GmbH | Compositions and methods for the treatment of ocular neovascularization |
| KR20220058577A (ko) | 2019-09-06 | 2022-05-09 | 노바리크 게엠베하 | 포도막염 치료를 위한 안과용 조성물 |
| EP3912622A1 (en) | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Oral film for safe administration of api |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496537A (en) * | 1995-03-23 | 1996-03-05 | Henry; Richard A. | Propofol hydrofluorocarbon propellant formulations |
| DE19536504C2 (de) | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| EP1124416A1 (en) * | 1999-03-15 | 2001-08-22 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
| CA2549524A1 (en) * | 2004-01-02 | 2005-07-28 | Wisconsin Alumni Research Foundation | Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| DE102004030044A1 (de) | 2004-06-22 | 2006-01-12 | Birken Gmbh | Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels |
| EP2099408B1 (en) * | 2006-11-28 | 2016-10-05 | Wisconsin Alumni Research Foundation | Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| ES2377152T3 (es) * | 2008-04-18 | 2012-03-22 | Novaliq Gmbh | Uso inhalativo e instilativo de alcanos semifluorados como vehículos de principios activos en la región intrapulmonar |
-
2009
- 2009-11-23 EP EP09014548A patent/EP2332525A1/en not_active Withdrawn
-
2010
- 2010-11-22 BR BR112012012108A patent/BR112012012108A2/pt not_active Application Discontinuation
- 2010-11-22 ES ES10778677.4T patent/ES2450423T3/es active Active
- 2010-11-22 JP JP2012539355A patent/JP5707009B2/ja active Active
- 2010-11-22 US US13/511,184 patent/US8796340B2/en active Active
- 2010-11-22 AU AU2010320823A patent/AU2010320823B2/en active Active
- 2010-11-22 KR KR1020127016348A patent/KR20120104262A/ko not_active Withdrawn
- 2010-11-22 CN CN201080052400.7A patent/CN102753159B/zh active Active
- 2010-11-22 MX MX2012005881A patent/MX2012005881A/es not_active Application Discontinuation
- 2010-11-22 EP EP10778677.4A patent/EP2503999B1/en active Active
- 2010-11-22 IN IN3130DEN2012 patent/IN2012DN03130A/en unknown
- 2010-11-22 WO PCT/EP2010/067938 patent/WO2011061332A1/en not_active Ceased
- 2010-11-22 CA CA2776855A patent/CA2776855C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011061332A1 (en) | 2011-05-26 |
| CA2776855C (en) | 2017-10-24 |
| JP5707009B2 (ja) | 2015-04-22 |
| US8796340B2 (en) | 2014-08-05 |
| IN2012DN03130A (https=) | 2015-09-18 |
| CA2776855A1 (en) | 2011-05-26 |
| MX2012005881A (es) | 2012-06-19 |
| JP2013511496A (ja) | 2013-04-04 |
| AU2010320823B2 (en) | 2014-06-26 |
| AU2010320823A1 (en) | 2012-07-12 |
| EP2503999B1 (en) | 2013-12-25 |
| BR112012012108A2 (pt) | 2016-04-05 |
| KR20120104262A (ko) | 2012-09-20 |
| US20120238639A1 (en) | 2012-09-20 |
| EP2332525A1 (en) | 2011-06-15 |
| EP2503999A1 (en) | 2012-10-03 |
| CN102753159B (zh) | 2014-03-12 |
| CN102753159A (zh) | 2012-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2450423T3 (es) | Composición farmacéutica que comprende propofol | |
| JP2021193091A (ja) | 疾患の処置のための鼻腔内エピネフリン製剤及び方法 | |
| US20140113971A1 (en) | Topical NSAID Compositions Having Sensate Component | |
| US5496537A (en) | Propofol hydrofluorocarbon propellant formulations | |
| US20150231130A1 (en) | Pharmaceutical composition comprising diamorphine for intranasal administration | |
| JP2023547040A (ja) | ピロロピリジン－アニリン化合物による、認知機能不全の処置方法 | |
| US20110237674A1 (en) | Topical nsaid compositions having sensate component | |
| ES2382911T3 (es) | Método de cardioprotección y neuroprotección mediante administración intravenosa de anestésicos volátiles halogenados | |
| ES2935684T3 (es) | Formulaciones de epinefrina intranasales y métodos para el tratamiento de enfermedades | |
| KR20100112632A (ko) | 수용성인 프로포폴 전구약물의 약제학적 수성 제제 | |
| JP2006504740A5 (https=) | ||
| PT2197492E (pt) | Novas composições à base de taxóides | |
| ES2972897T3 (es) | Composiciones descongestionantes nasales que comprenden mentol, dexpantenol e hialuronato de sodio | |
| JP2023011818A (ja) | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 | |
| EP4225271A1 (en) | Compositions and methods for lowering intracranial pressure by intranasal agent administration | |
| CN101088499B (zh) | 细辛脑干乳剂及其制备方法与应用 | |
| HK1172272A (en) | Pharmaceutical composition comprising propofol | |
| EP4483870B1 (en) | Aqueous retinol formulations | |
| WO2025205960A1 (ja) | エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ | |
| HK40092206A (zh) | 鼻内肾上腺素制剂及治疗疾病的方法 | |
| HK40054634B (en) | Aqueous paediatric retinol formulations |